This document provides an overview of non-narcotic analgesics, also known as nonsteroidal anti-inflammatory drugs (NSAIDs). It discusses the mechanisms of action and pharmacological properties of various classes of NSAIDs, including salicylates, para-aminophenol derivatives, propionic acid derivatives, acetic acid derivatives, pyrazolone derivatives, and oxicam derivatives. The document also covers preferential and selective COX-2 inhibitors as well as factors to consider when choosing an appropriate NSAID for different pain conditions.
This document discusses NSAIDs (nonsteroidal anti-inflammatory drugs) used for dental pain relief. It begins by introducing NSAIDs and their analgesic, antipyretic, and anti-inflammatory properties. NSAIDs are then classified based on their chemical structure and clinical applications. The mechanisms of action for their analgesic, antipyretic and anti-inflammatory effects are described. Common adverse effects are also outlined. Specific NSAIDs discussed in more detail include aspirin and ibuprofen, focusing on their pharmacological actions, uses, dosages and adverse effects.
NSAIDs have an extremely safe profile when used for acute dental pain.
Within a group they tend to have similar characteristics & tolerability. There is little difference in clinical efficacy among the NSAIDs when used at equivalent doses.
Rather, differences among compounds usually relate to dosing regimens (related to compound’s elimination half –life), route of administration, & tolerability profile.
So, clinician should have a thorough knowledge of mechanism of action, pharmacokinetics, pharmacodynamics, dosage & adverse effects of each drug before prescribing the same.
Non-steroidal anti-inflammatory drugs (NSAIDs) work by inhibiting the enzyme cyclooxygenase (COX) and subsequent prostaglandin synthesis. They are classified based on selectivity for COX-1 vs COX-2. Common side effects include gastric irritation, while selective COX-2 inhibitors were developed to reduce this but increase cardiovascular risk. NSAIDs are used for analgesic, antipyretic and anti-inflammatory effects in conditions like arthritis, but choice depends on safety profile and potency needed.
This document provides an overview of analgesic drugs including definitions of pain, classifications of analgesics, and details on specific drugs. It discusses:
1) Definitions of pain and classifications as acute vs chronic and by severity. Analgesics are classified as non-opioid (e.g. NSAIDs, paracetamol) or opioid.
2) Mechanisms of action for different classes of drugs including NSAIDs inhibiting COX enzymes and paracetamol inhibiting prostaglandin synthesis in the CNS.
3) Specific drugs like aspirin, ibuprofen, naproxen, and details on indications, mechanisms of action, and adverse effects. Selective COX-2 inhibitors and
This document provides an overview of nonsteroidal anti-inflammatory drugs (NSAIDs). It discusses their classification, mechanism of action involving inhibition of prostaglandin synthesis, beneficial effects, toxicities, and individual drug profiles. NSAIDs are a chemically diverse class of drugs that reduce pain, fever, and inflammation by blocking cyclooxygenase (COX) enzymes and subsequent prostaglandin production. While effective analgesics, NSAIDs can cause adverse effects like gastric irritation, bleeding risks, and interference with other drugs due to competition for protein binding sites.
NSAIDs have analgesic, antipyretic and anti-inflammatory properties. They work by inhibiting cyclooxygenase (COX) enzymes and reducing prostaglandin production. NSAIDs are classified as nonselective COX inhibitors like aspirin, preferential COX-2 inhibitors like nimesulide, or selective COX-2 inhibitors like celecoxib. Common adverse effects include gastrointestinal irritation. NSAIDs are used to treat pain, fever, and inflammation conditions like arthritis.
Non steroidal anti inflammatory drugs (NSAIDS)Girmay Fitiwi
NonSteroidalAntiInflammatoryDrugs (NSAIDs) are a heterogeneous class of drugs that inhibit cyclooxygenase (COX) enzymes and reduce prostaglandin production, providing anti-inflammatory, analgesic, and antipyretic effects. They are used to treat mild to moderate pain, chronic inflammation, and postoperative pain. NSAIDs work by inhibiting both COX-1 and COX-2 enzymes, with COX-1 inhibition causing side effects and COX-2 inhibition providing therapeutic effects. Common NSAIDs discussed in more detail include diclofenac, ketorolac, and aspirin.
This document discusses NSAIDs (nonsteroidal anti-inflammatory drugs) used for dental pain relief. It begins by introducing NSAIDs and their analgesic, antipyretic, and anti-inflammatory properties. NSAIDs are then classified based on their chemical structure and clinical applications. The mechanisms of action for their analgesic, antipyretic and anti-inflammatory effects are described. Common adverse effects are also outlined. Specific NSAIDs discussed in more detail include aspirin and ibuprofen, focusing on their pharmacological actions, uses, dosages and adverse effects.
NSAIDs have an extremely safe profile when used for acute dental pain.
Within a group they tend to have similar characteristics & tolerability. There is little difference in clinical efficacy among the NSAIDs when used at equivalent doses.
Rather, differences among compounds usually relate to dosing regimens (related to compound’s elimination half –life), route of administration, & tolerability profile.
So, clinician should have a thorough knowledge of mechanism of action, pharmacokinetics, pharmacodynamics, dosage & adverse effects of each drug before prescribing the same.
Non-steroidal anti-inflammatory drugs (NSAIDs) work by inhibiting the enzyme cyclooxygenase (COX) and subsequent prostaglandin synthesis. They are classified based on selectivity for COX-1 vs COX-2. Common side effects include gastric irritation, while selective COX-2 inhibitors were developed to reduce this but increase cardiovascular risk. NSAIDs are used for analgesic, antipyretic and anti-inflammatory effects in conditions like arthritis, but choice depends on safety profile and potency needed.
This document provides an overview of analgesic drugs including definitions of pain, classifications of analgesics, and details on specific drugs. It discusses:
1) Definitions of pain and classifications as acute vs chronic and by severity. Analgesics are classified as non-opioid (e.g. NSAIDs, paracetamol) or opioid.
2) Mechanisms of action for different classes of drugs including NSAIDs inhibiting COX enzymes and paracetamol inhibiting prostaglandin synthesis in the CNS.
3) Specific drugs like aspirin, ibuprofen, naproxen, and details on indications, mechanisms of action, and adverse effects. Selective COX-2 inhibitors and
This document provides an overview of nonsteroidal anti-inflammatory drugs (NSAIDs). It discusses their classification, mechanism of action involving inhibition of prostaglandin synthesis, beneficial effects, toxicities, and individual drug profiles. NSAIDs are a chemically diverse class of drugs that reduce pain, fever, and inflammation by blocking cyclooxygenase (COX) enzymes and subsequent prostaglandin production. While effective analgesics, NSAIDs can cause adverse effects like gastric irritation, bleeding risks, and interference with other drugs due to competition for protein binding sites.
NSAIDs have analgesic, antipyretic and anti-inflammatory properties. They work by inhibiting cyclooxygenase (COX) enzymes and reducing prostaglandin production. NSAIDs are classified as nonselective COX inhibitors like aspirin, preferential COX-2 inhibitors like nimesulide, or selective COX-2 inhibitors like celecoxib. Common adverse effects include gastrointestinal irritation. NSAIDs are used to treat pain, fever, and inflammation conditions like arthritis.
Non steroidal anti inflammatory drugs (NSAIDS)Girmay Fitiwi
NonSteroidalAntiInflammatoryDrugs (NSAIDs) are a heterogeneous class of drugs that inhibit cyclooxygenase (COX) enzymes and reduce prostaglandin production, providing anti-inflammatory, analgesic, and antipyretic effects. They are used to treat mild to moderate pain, chronic inflammation, and postoperative pain. NSAIDs work by inhibiting both COX-1 and COX-2 enzymes, with COX-1 inhibition causing side effects and COX-2 inhibition providing therapeutic effects. Common NSAIDs discussed in more detail include diclofenac, ketorolac, and aspirin.
Cyclooxygenase 2 inhibitors and non spesific non steroidal antiNur Hajriya
This document discusses nonsteroidal anti-inflammatory drugs (NSAIDs) and their mechanisms of action, effects, and examples. It notes that NSAIDs inhibit the cyclooxygenase (COX) enzymes COX-1 and COX-2, which are involved in prostaglandin synthesis. COX-1 mediates important homeostatic functions while COX-2 mediates inflammation. NSAIDs have analgesic, anti-inflammatory, and antipyretic effects. Examples mentioned include celecoxib, rofecoxib, valdecoxib, and parecoxib. The document also summarizes the clinical uses, side effects, classifications, and descriptions of several common NSAIDs like aspirin and acet
This document discusses various classes of nonsteroidal anti-inflammatory drugs (NSAIDs) including their mechanisms of action, classifications, and individual drug properties. Key points include: NSAIDs work by inhibiting cyclooxygenase (COX) enzymes and reducing prostaglandin production, providing analgesic, antipyretic, and anti-inflammatory effects. Common NSAID classes described are salicylates, propionic acid derivatives, fenamates, enolic acid derivatives, acetic acid derivatives, and pyrazolones. Individual drugs like aspirin, ibuprofen, ketoprofen, indomethacin, and metamizol are highlighted with details on their pharmacokinetics, uses
This document discusses NSAIDs (non-steroidal anti-inflammatory drugs) and their role in controlling inflammation. It begins by describing the normal inflammatory response and how chronic inflammation disrupts the off switch. It then discusses the various mediators involved in inflammation and the four classic signs. The document goes on to explain the pathways involved like eicosanoids and cyclooxygenase, the mechanism of action and types of NSAIDs, potential dietary interventions using EPA, and treatments for conditions like gouty arthritis.
The document discusses various aspects of NSAIDs (Non-Steroidal Anti-Inflammatory Drugs). It defines NSAIDs and describes their analgesic, antipyretic and anti-inflammatory effects. It classifies different types of NSAIDs based on their selectivity for COX-1 and COX-2 enzymes. It also discusses the mechanisms of action, pharmacological properties, uses, doses and adverse effects of several common NSAIDs like aspirin, ibuprofen, ketorolac, diclofenac, celecoxib, paracetamol and nabumetone.
Nonsteroidal anti-inflammatory drugs (NSAIDs) work by inhibiting the prostaglandin synthase enzymes, namely cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). Traditional NSAIDs nonselectively inhibit both COX-1 and COX-2, whereas some newer NSAIDs preferentially or selectively inhibit COX-2. NSAIDs are used to reduce inflammation, fever, and pain in conditions like arthritis but can cause adverse gastrointestinal, renal, and cardiovascular effects. Aspirin irreversibly inhibits COX-1 and COX-2 and is used at low doses as an antiplatelet drug to reduce the risk of cardiovascular
The document discusses analgesics used to treat pain. It defines analgesics as drugs that selectively relieve pain without significantly altering consciousness. Analgesics are classified as non-opioid or opioid. Common non-opioid analgesics discussed include aspirin, ibuprofen, diclofenac, and paracetamol. Opioid analgesics discussed include codeine, hydrocodone, morphine, and tramadol. The document covers the mechanisms of action, dosages, and adverse effects of various analgesic drugs used in dentistry.
The document discusses different types of NSAIDs and acetaminophen, their mechanisms of action, and adverse effects. It describes how aspirin and nonselective NSAIDs like ibuprofen inhibit both COX-1 and COX-2 isoforms, decreasing prostaglandin synthesis throughout the body. More recent COX-2 selective inhibitors like celecoxib were developed to reduce gastrointestinal toxicity. Acetaminophen is only a weak inhibitor of COX-1 and COX-2 and may inhibit COX-3 in the CNS. While NSAIDs can cause gastrointestinal ulceration and renal damage, acetaminophen is generally safe at therapeutic doses but overdose can cause hepatotoxicity.
The document discusses NSAIDs (non-steroidal anti-inflammatory drugs) such as aspirin. It explains that NSAIDs work by inhibiting the cyclooxygenase (COX) enzymes involved in prostaglandin synthesis, thereby reducing inflammation. NSAIDs are effective for mild to moderate pain relief but opioids are preferred for more severe pain. Common side effects of NSAIDs include gastric irritation and renal problems due to reduced prostaglandin production in the stomach and kidneys. The document provides details on the classification, mechanisms of action, and uses of various NSAIDs.
This document discusses non-steroidal anti-inflammatory drugs (NSAIDs). It covers the classification of NSAIDs, their general mechanism of action involving inhibition of cyclooxygenase (COX) enzymes, and their beneficial and risk factors. Specific NSAIDs discussed include aspirin, diflunisal, piroxicam, indomethacin, ibuprofen, ketorolac, mephenamic acid, diclofenac, and selective COX-2 inhibitors. The roles of NSAIDs in periodontics and controlling disease progression are examined. Current recommendations and the role of NSAIDs in the future are also mentioned.
The document provides an overview of non-steroidal anti-inflammatory drugs (NSAIDs). It discusses that NSAIDs are widely used to treat minor pain, edema, and tissue damage from inflammation. Their main mechanism of action is inhibiting cyclooxygenase (COX) enzymes, which reduces the formation of prostaglandins. Most NSAIDs inhibit both COX-1 and COX-2, though some have greater selectivity for one or the other. Inhibition of COX enzymes contributes to the therapeutic effects as well as some toxicities like gastrointestinal irritation. The document reviews several classes of NSAIDs and provides details on their structures, mechanisms of action, absorption, metabolism, and elimination.
This document summarizes nonsteroidal anti-inflammatory drugs (NSAIDs). It discusses how NSAIDs work by inhibiting cyclooxygenase (COX) enzymes and thereby decreasing production of prostaglandins involved in pain, fever and inflammation. NSAIDs are classified based on selectivity for COX-1 versus COX-2. Key points covered include the physiological roles of prostaglandins, properties and side effects of common NSAIDs like aspirin, ibuprofen, naproxen, and COX-2 inhibitors, as well as their various clinical uses and precautions.
NSAIDs work by inhibiting the cyclooxygenase (COX) enzymes COX-1 and COX-2, which decreases the production of prostaglandins and leads to their anti-inflammatory, analgesic, and antipyretic effects. Aspirin irreversibly inhibits COX-1 and COX-2, while other NSAIDs reversibly inhibit the enzymes. NSAIDs are used to treat pain, fever, and inflammation conditions but can cause gastrointestinal adverse effects by reducing protective prostaglandins in the stomach. Their antiplatelet effect from COX-1 inhibition also increases bleeding risk. Acetaminophen is an effective antipyretic that is preferred in pregnancy due to safety.
This document discusses non-steroidal anti-inflammatory drugs (NSAIDs), including their classification, mechanisms of action, therapeutic uses, and adverse effects. NSAIDs work by inhibiting the enzyme cyclooxygenase (COX) to reduce pain, fever, and inflammation. While most NSAIDs inhibit both COX-1 and COX-2, selective COX-2 inhibitors like celecoxib may have fewer gastrointestinal side effects. Common adverse effects include gastrointestinal toxicity, renal failure, and increased risk of cardiovascular and liver problems. The document also briefly discusses aspirin and paracetamol/acetaminophen.
Inflammation is the body's natural response to injury or infection and involves increased blood flow, immune cell activity, and pain. Nonsteroidal anti-inflammatory drugs (NSAsIDs) like aspirin work by inhibiting the cyclooxygenase enzymes, decreasing the production of prostaglandins which mediate inflammation. Aspirin is unique in that it irreversibly inhibits cyclooxygenase. At normal doses, aspirin is hydrolyzed to salicylate which has analgesic, antipyretic, and anti-inflammatory effects. However, NSAIDs can cause adverse gastrointestinal, platelet, renal, and respiratory effects that require consideration of risks and benefits of long-term use.
This document provides information on non-narcotic analgesics (NSAIDs) that have analgesic, antipyretic, and anti-inflammatory properties. It discusses the inflammatory process and pain pathway, how NSAIDs work by inhibiting prostaglandin synthesis via inhibition of cyclooxygenase enzymes, and the classification of various NSAIDs including aspirin, ibuprofen, naproxen, indomethacin, and others. It covers the pharmacological actions, pharmacokinetics, uses, and adverse effects of different NSAID classes.
This document provides information on analgesics and anti-inflammatory drugs. It begins by defining analgesics as drugs that relieve pain without altering consciousness, and anaesthesia as loss of sensation. It then classifies analgesics into two main groups - opioid analgesics like morphine and non-opioid analgesics like NSAIDs. The document goes on to describe various opioid and non-opioid analgesics in detail, their mechanisms of action, uses, and adverse effects. It focuses on the role of prostaglandins in pain and inflammation, and how different NSAIDs work by inhibiting prostaglandin synthesis.
This document discusses various drugs used in orthodontics, including their mechanisms of action and effects. It covers prostaglandins and leukotrienes, which are involved in inflammation and tooth movement. Non-steroidal anti-inflammatory drugs (NSAIDs) like aspirin, ibuprofen, and diclofenac are described as well as their analgesic, antipyretic and anti-inflammatory properties from inhibiting prostaglandin synthesis. Preferential COX-2 inhibitors and specific drugs like nimesulide and meloxicam are also summarized.
Docking based screening uses computational molecular docking to virtually screen chemical compound databases and identify which compounds are most likely to interact with a target receptor or protein. It involves docking candidate ligands to the binding site of target proteins and ranking the binding affinity scores. Popular docking software uses systematic, stochastic, or deterministic search algorithms along with force field, empirical, or knowledge-based scoring functions. Molecular docking has applications in target identification, drug repositioning, and polypharmacology. Challenges include incomplete target databases and accounting for protein flexibility.
Cyclooxygenase 2 inhibitors and non spesific non steroidal antiNur Hajriya
This document discusses nonsteroidal anti-inflammatory drugs (NSAIDs) and their mechanisms of action, effects, and examples. It notes that NSAIDs inhibit the cyclooxygenase (COX) enzymes COX-1 and COX-2, which are involved in prostaglandin synthesis. COX-1 mediates important homeostatic functions while COX-2 mediates inflammation. NSAIDs have analgesic, anti-inflammatory, and antipyretic effects. Examples mentioned include celecoxib, rofecoxib, valdecoxib, and parecoxib. The document also summarizes the clinical uses, side effects, classifications, and descriptions of several common NSAIDs like aspirin and acet
This document discusses various classes of nonsteroidal anti-inflammatory drugs (NSAIDs) including their mechanisms of action, classifications, and individual drug properties. Key points include: NSAIDs work by inhibiting cyclooxygenase (COX) enzymes and reducing prostaglandin production, providing analgesic, antipyretic, and anti-inflammatory effects. Common NSAID classes described are salicylates, propionic acid derivatives, fenamates, enolic acid derivatives, acetic acid derivatives, and pyrazolones. Individual drugs like aspirin, ibuprofen, ketoprofen, indomethacin, and metamizol are highlighted with details on their pharmacokinetics, uses
This document discusses NSAIDs (non-steroidal anti-inflammatory drugs) and their role in controlling inflammation. It begins by describing the normal inflammatory response and how chronic inflammation disrupts the off switch. It then discusses the various mediators involved in inflammation and the four classic signs. The document goes on to explain the pathways involved like eicosanoids and cyclooxygenase, the mechanism of action and types of NSAIDs, potential dietary interventions using EPA, and treatments for conditions like gouty arthritis.
The document discusses various aspects of NSAIDs (Non-Steroidal Anti-Inflammatory Drugs). It defines NSAIDs and describes their analgesic, antipyretic and anti-inflammatory effects. It classifies different types of NSAIDs based on their selectivity for COX-1 and COX-2 enzymes. It also discusses the mechanisms of action, pharmacological properties, uses, doses and adverse effects of several common NSAIDs like aspirin, ibuprofen, ketorolac, diclofenac, celecoxib, paracetamol and nabumetone.
Nonsteroidal anti-inflammatory drugs (NSAIDs) work by inhibiting the prostaglandin synthase enzymes, namely cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). Traditional NSAIDs nonselectively inhibit both COX-1 and COX-2, whereas some newer NSAIDs preferentially or selectively inhibit COX-2. NSAIDs are used to reduce inflammation, fever, and pain in conditions like arthritis but can cause adverse gastrointestinal, renal, and cardiovascular effects. Aspirin irreversibly inhibits COX-1 and COX-2 and is used at low doses as an antiplatelet drug to reduce the risk of cardiovascular
The document discusses analgesics used to treat pain. It defines analgesics as drugs that selectively relieve pain without significantly altering consciousness. Analgesics are classified as non-opioid or opioid. Common non-opioid analgesics discussed include aspirin, ibuprofen, diclofenac, and paracetamol. Opioid analgesics discussed include codeine, hydrocodone, morphine, and tramadol. The document covers the mechanisms of action, dosages, and adverse effects of various analgesic drugs used in dentistry.
The document discusses different types of NSAIDs and acetaminophen, their mechanisms of action, and adverse effects. It describes how aspirin and nonselective NSAIDs like ibuprofen inhibit both COX-1 and COX-2 isoforms, decreasing prostaglandin synthesis throughout the body. More recent COX-2 selective inhibitors like celecoxib were developed to reduce gastrointestinal toxicity. Acetaminophen is only a weak inhibitor of COX-1 and COX-2 and may inhibit COX-3 in the CNS. While NSAIDs can cause gastrointestinal ulceration and renal damage, acetaminophen is generally safe at therapeutic doses but overdose can cause hepatotoxicity.
The document discusses NSAIDs (non-steroidal anti-inflammatory drugs) such as aspirin. It explains that NSAIDs work by inhibiting the cyclooxygenase (COX) enzymes involved in prostaglandin synthesis, thereby reducing inflammation. NSAIDs are effective for mild to moderate pain relief but opioids are preferred for more severe pain. Common side effects of NSAIDs include gastric irritation and renal problems due to reduced prostaglandin production in the stomach and kidneys. The document provides details on the classification, mechanisms of action, and uses of various NSAIDs.
This document discusses non-steroidal anti-inflammatory drugs (NSAIDs). It covers the classification of NSAIDs, their general mechanism of action involving inhibition of cyclooxygenase (COX) enzymes, and their beneficial and risk factors. Specific NSAIDs discussed include aspirin, diflunisal, piroxicam, indomethacin, ibuprofen, ketorolac, mephenamic acid, diclofenac, and selective COX-2 inhibitors. The roles of NSAIDs in periodontics and controlling disease progression are examined. Current recommendations and the role of NSAIDs in the future are also mentioned.
The document provides an overview of non-steroidal anti-inflammatory drugs (NSAIDs). It discusses that NSAIDs are widely used to treat minor pain, edema, and tissue damage from inflammation. Their main mechanism of action is inhibiting cyclooxygenase (COX) enzymes, which reduces the formation of prostaglandins. Most NSAIDs inhibit both COX-1 and COX-2, though some have greater selectivity for one or the other. Inhibition of COX enzymes contributes to the therapeutic effects as well as some toxicities like gastrointestinal irritation. The document reviews several classes of NSAIDs and provides details on their structures, mechanisms of action, absorption, metabolism, and elimination.
This document summarizes nonsteroidal anti-inflammatory drugs (NSAIDs). It discusses how NSAIDs work by inhibiting cyclooxygenase (COX) enzymes and thereby decreasing production of prostaglandins involved in pain, fever and inflammation. NSAIDs are classified based on selectivity for COX-1 versus COX-2. Key points covered include the physiological roles of prostaglandins, properties and side effects of common NSAIDs like aspirin, ibuprofen, naproxen, and COX-2 inhibitors, as well as their various clinical uses and precautions.
NSAIDs work by inhibiting the cyclooxygenase (COX) enzymes COX-1 and COX-2, which decreases the production of prostaglandins and leads to their anti-inflammatory, analgesic, and antipyretic effects. Aspirin irreversibly inhibits COX-1 and COX-2, while other NSAIDs reversibly inhibit the enzymes. NSAIDs are used to treat pain, fever, and inflammation conditions but can cause gastrointestinal adverse effects by reducing protective prostaglandins in the stomach. Their antiplatelet effect from COX-1 inhibition also increases bleeding risk. Acetaminophen is an effective antipyretic that is preferred in pregnancy due to safety.
This document discusses non-steroidal anti-inflammatory drugs (NSAIDs), including their classification, mechanisms of action, therapeutic uses, and adverse effects. NSAIDs work by inhibiting the enzyme cyclooxygenase (COX) to reduce pain, fever, and inflammation. While most NSAIDs inhibit both COX-1 and COX-2, selective COX-2 inhibitors like celecoxib may have fewer gastrointestinal side effects. Common adverse effects include gastrointestinal toxicity, renal failure, and increased risk of cardiovascular and liver problems. The document also briefly discusses aspirin and paracetamol/acetaminophen.
Inflammation is the body's natural response to injury or infection and involves increased blood flow, immune cell activity, and pain. Nonsteroidal anti-inflammatory drugs (NSAsIDs) like aspirin work by inhibiting the cyclooxygenase enzymes, decreasing the production of prostaglandins which mediate inflammation. Aspirin is unique in that it irreversibly inhibits cyclooxygenase. At normal doses, aspirin is hydrolyzed to salicylate which has analgesic, antipyretic, and anti-inflammatory effects. However, NSAIDs can cause adverse gastrointestinal, platelet, renal, and respiratory effects that require consideration of risks and benefits of long-term use.
This document provides information on non-narcotic analgesics (NSAIDs) that have analgesic, antipyretic, and anti-inflammatory properties. It discusses the inflammatory process and pain pathway, how NSAIDs work by inhibiting prostaglandin synthesis via inhibition of cyclooxygenase enzymes, and the classification of various NSAIDs including aspirin, ibuprofen, naproxen, indomethacin, and others. It covers the pharmacological actions, pharmacokinetics, uses, and adverse effects of different NSAID classes.
This document provides information on analgesics and anti-inflammatory drugs. It begins by defining analgesics as drugs that relieve pain without altering consciousness, and anaesthesia as loss of sensation. It then classifies analgesics into two main groups - opioid analgesics like morphine and non-opioid analgesics like NSAIDs. The document goes on to describe various opioid and non-opioid analgesics in detail, their mechanisms of action, uses, and adverse effects. It focuses on the role of prostaglandins in pain and inflammation, and how different NSAIDs work by inhibiting prostaglandin synthesis.
This document discusses various drugs used in orthodontics, including their mechanisms of action and effects. It covers prostaglandins and leukotrienes, which are involved in inflammation and tooth movement. Non-steroidal anti-inflammatory drugs (NSAIDs) like aspirin, ibuprofen, and diclofenac are described as well as their analgesic, antipyretic and anti-inflammatory properties from inhibiting prostaglandin synthesis. Preferential COX-2 inhibitors and specific drugs like nimesulide and meloxicam are also summarized.
Docking based screening uses computational molecular docking to virtually screen chemical compound databases and identify which compounds are most likely to interact with a target receptor or protein. It involves docking candidate ligands to the binding site of target proteins and ranking the binding affinity scores. Popular docking software uses systematic, stochastic, or deterministic search algorithms along with force field, empirical, or knowledge-based scoring functions. Molecular docking has applications in target identification, drug repositioning, and polypharmacology. Challenges include incomplete target databases and accounting for protein flexibility.
This document provides information on respiratory safety pharmacology studies. It discusses evaluating the respiratory system as one of the primary organ systems in safety pharmacology. The respiratory system consists of the pumping apparatus and gas exchange unit. Methods are described to assess the function of these units in rats, dogs and monkeys. Ventilatory parameters and lung mechanics can be measured to evaluate the pumping apparatus. Gas exchange is assessed by measuring airway resistance, lung compliance and end-tidal carbon dioxide. Surgical procedures are outlined for chronic catheter placement to measure respiratory pressures. Various restrained and non-restrained methodologies are discussed to evaluate respiratory function in conscious animals.
Research design provides a blueprint for conducting research and answering questions. It includes determining the problem being studied, how data will be collected and analyzed, and the types of research. There are different types of research designs based on their objectives, such as descriptive research that describes a situation, and exploratory research that investigates little known areas. Research methods can be quantitative using measurements and statistics, or qualitative using descriptions. Experimental research uses treatments and control groups, while survey research uses questionnaires. Proper research design is needed to efficiently answer research questions with minimal time and resources.
This document discusses computer-aided drug design (CADD) and the use of pharmacophore modeling to aid in the drug discovery process. It provides details on the basic principles of developing a 3D pharmacophore model, including identifying active conformations of ligands that overlap on common pharmacophore elements. The selection of appropriate pharmacophore elements from a set of active ligands is also covered. Methods for generating pharmacophore models, both manually and automatically, are described.
1. The document discusses various screening models used to test potential anti-fertility agents, including both in vitro and in vivo methods.
2. In vivo screening models include tests like HCG-induced ovulation in rats and cupric acetate-induced ovulation in rabbits to assess anti-ovulatory effects, as well as assays measuring estrogenic activity like vaginal opening and the four-day uterine weight test.
3. In vitro screening methods involve estrogen receptor binding assays to determine affinity for estrogen receptor sites and assess estrogenic or anti-estrogenic activity.
This document discusses androgens and anabolic steroids. It begins by defining androgens as male sex hormones such as testosterone that are produced in the testes and adrenal cortex. It then covers the production, actions, and mechanisms of androgens. The document also discusses the uses, side effects, and classifications of androgens and anabolic steroids. It concludes by examining antiandrogens and drugs that inhibit androgen synthesis.
ROLES AND RESPONSIBILITIES OF sponsor and CRO.pptxPraveen kumar S
The document discusses the roles and responsibilities of clinical trial sponsors and contract research organizations (CROs). It outlines that sponsors are responsible for initiating, managing, and financing clinical trials in accordance with good clinical practice guidelines. They must select investigators, monitor trials, ensure regulatory approval is obtained, and address safety issues. CROs assist sponsors by providing outsourced clinical research services like monitoring, data management, and regulatory support. Sponsors and CROs have legal contracts defining their responsibilities for conducting research properly and protecting participant safety.
The document discusses various methods of pharmacovigilance including passive surveillance methods like spontaneous reporting and case series, as well as active surveillance methods like sentinel sites and drug event monitoring. Comparative observational studies that can be used include cohort studies, case-control studies, and cross-sectional studies. Descriptive studies are also important for understanding the natural history of diseases and monitoring drug utilization. The key goal of pharmacovigilance is to detect, understand, and prevent adverse drug reactions.
This document discusses antiemetics and prokinetics. It begins by describing the physiology of vomiting and stimuli pathways and centers that mediate the emetic reflex. It then covers various classes of antiemetics including dopamine D2 antagonists, 5-HT3 antagonists, antimuscarinics, neuroleptics, and other agents. Prokinetics are also discussed, focusing on their mechanisms of action to enhance gastrointestinal motility. Common prokinetic drugs like metoclopramide, cisapride, and erythromycin are described along with their uses and adverse effects.
This document discusses immunostimulants, which are drugs that modulate the immune response to increase immunoresponsiveness in immunodeficient patients. It provides examples of currently used immunostimulant drugs like levamisole, thalidomide, BCG vaccine, interferons, and interleukin-2. It also discusses immunization methods, including active immunization using vaccines and passive immunization using antisera and immunoglobulins. Vaccines stimulate host immunity by presenting antigens to induce antibody production, while antisera provide ready-made antibodies for immediate protection.
Antioxidants treatment for diabetes mellitus.pptxPraveen kumar S
Diabetes mellitus causes oxidative stress through increased production of reactive oxygen species. This damages cells and tissues over time. The document discusses several pathways by which ROS are generated in diabetes and damage occurs, including advanced glycation end products, the polyol pathway, and activation of protein kinase C. It also describes the Nrf2/Keap1 pathway which regulates the body's antioxidant response. Various natural and synthetic antioxidants that can help reduce oxidative stress in diabetes are reviewed, such as alpha-lipoic acid, vitamins C and E, flavonoids, and plant extracts. Targeting specific pathways like the polyol pathway or AGE formation with inhibitors or antioxidants may help prevent complications of diabetes.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...rightmanforbloodline
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Versio
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kolb, Ian Q. Whishaw, Verified Chapters 1 - 16, Complete Newest Version
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
3. INTRODUCTION
The Nonsteroidal antiinflammatory drugs (NSAIDs) and
antipyretic analegsics are a class of drugs that have
analegsic,antipyretic and antiinflammatory action.
In contrast to morphine they do not depress CNS, and do not
produce physical depandence, have no abuse liability and are
particularly effective in inflammatory pain.
They also called nonnarcotic , nonopoid or aspirin –like
analegesics.
They act primarily on peripheral pain mechanisms.
They are more commonly employed and many are the over-the-
counter Or non prescription drugs.
3
5. MECHANISM OF ACTION OF PROSTAGLANDIN
SYNTHESIS INHIBITOR:
SOURCE : SCIENCE DIRECT.COM 5
6. Action of NSAID
ANALGESIA
PGs induce hyperalgesia by affecting the transducing property of
free nerve endings so that stimuli that normally do not elict pain are able
to do so
NSAID block the pain sensitizing mechanism induced by bradykinin
TNFalpha, interleukin (Ils) and other algesic substance primarily by
inhibiting COX -2.
ANTIPYRESIS
NSAID lower body temperature in fever ,but do not cause
hypothermia in normothermic individuals.
NSAID block the action of pyrogens but not that PGE2 injected into
hypothalamus.
Fever can occur through non PG mediated mechanism as well.
6
7. ANTIINFLAMMATORY
Most important mechanism of antiinflammatory action of NSAIDs
is considered to be inhibition of COX 2 mediated enhanced PG synthesis
at site of injury.
PGs are only one of the mediator of inflammation and inhibition
of COX does not depress the production of other mediators like LTs,
PAF, cytokinins,etc..
Activated endothelial cells express adhesion molecules (ELAM-1,
ICAM -1) on their surface and play a key role in directing circulating
leukocytes to the site of inflammation(chemotaxis)
DYSMENORRHOEA
Level of PGs in menstrual flow ,endometrial biopsy and that
PGF2alpha metabolite in circulation are raised in dysmennorhea women.
Intermittent ischemia and myometrium is probably responsible for
menstrual cramps.
NSAIDs lower uterine PGs levels – afford excellent relief 60-70%
7
8. ANTIPLATELET
NSAIDs inhibit synthesis of both proaggregatory (TXA2) and
antiaggregatory (PGI2) Therapeutic doses of most NSAIDs inhibit platelet
aggregation and prolong bleeding time.
Aspirin is highly active ,because it acetylate platelet COX irreversiably
in portal circulation before getting deacetylated by first pass metabolism in
liver.
8
10. 1. SALICYLATES
Are the salt of salicylic acid ,
Eg; methyl salicylate ,sodium salicylate, acetyl salicylic acid(aspirin)
Aspirin is taken as prototype.
PHARMACOLOGICAL ACTIONS:
1.ANALEGSIA:
IS good analgesic and relive pain of inflammatory origin.
aspirin relieve pain in connective tissue but in visceral pain aspirin
ineffective.
2.ANTIPYRETIC ACTION:
In presence of fever , salicylate bring down the temperature to normal
level.
Aspirin inhibits PG synthesis in the hypothalamus and reset the
thermostat at the normal level bringing down the temperature.
10
11. ANTI-INFLAMMATORYACTION
Higher doses 4-6 g/ day signs of inflammation like tenderness ,
swelling, erythma and pain are all reduced.
PG synthesis inhibition – PGs present in inflammatory tissues are
responsible for oedema,erythma and pain.
RESPIRATION:
Salicylate increase consumption of oxygen by skeletal muscle. As
result increased co2 production .
Salicylate also directly stimulate the medullary respiratory centre.
Both increase rate and depth of respiration.
ACID-BASE ELECTROLYTE BALANCE:
In anti-inflammatory doses ,salicylate produce significant respiratory
stimulation –more co2 is washed out result respiratory alkalosis;PH
become alkaline,compensated by increased excretion of HCO3- in
urine accompained by Na+,k+ and water. PH return to normal.is
known as respiratory alkaosis.
11
12. OTHERACTION…
GI Tract – gastric irritation ,epigastric distress
Immunological effects- Higher doses supress antigen antibody
reaction and antibody production.
Blood – platelet aggregation.
Local effect- keratolytic and mild antiseptic and fungistatic property.
Health atoz.in
12
13. ADVERSEEFFECTS:
Nausea ,vomiting,epigastric distress,peptic ulcer.
Nephrotoxicity
Headche
Rashes,urticaria
Haemolysis
Hepatotoxicity
Reye’s syndrome
Pregnancy – delay on set of labor
13
14. 2.PARA-AMINOPHENOLDERIVATIVES
PARACETAMOL (ACETOAMINOPHEN)
Is an metabolite of phenacetin found to be safer and effective.
ACTION:
It has analgesic and good antipyretic and weak antiinflammatory
properties.
Paracetamol iss active on cyclooxygenase in the brain which accounts
for antipyretic action.in presence of peroxide present at the site of
inflammation ,poor ability to inhibit cyclooxygenase.
MECHANISM OFACTION:
A small portion of paracetamol is metabolised to highly reactive
intermediate –N-acetyl-benzoquinone –imnine is detoxified
generally by conjugation with glutathione.
14
16. ADVERSEEFFECTS
Large doses taken –acute paracetamol poisoning results.
Nausea,vomiting,anorexia, abdominal pain.
I s hepatotoxic &cause severe hepatic damage.
Nephrotoxicity may result in acute renal failure.
Indian mart.in
16
17. 3.PROPIONICACIDDERIVATIVES
IBUPROFEN
Is better tolerated than aspirin .
Analgesic, antipyretic and antiinflammatory efficacy is slight lower
than aspirin.
Is avaliable for oral ,parentral,and topical use.
FLUBIPROFEN
Is used on eye for its anti-inflammatory properties.
USES:
As an analgesic in painful conditions.
In fever.
soft tissue injuries, fractures,tooth extraction,to relieve post
operative pain,dysmenorrhoea and osteoarthritis
Gout.
17
18. ACETICACIDDERIVATIVES
KETOROLAC
PGs synthesis inhibitor having good analgesic and antinflammatory
properties.to relive post operative pain.
INDOMETACIN
Potent anti-inflammatory agent,anti pyretic and good analgesic.
USES:
For closure of patent ductus arterious in premature infants.
Effectve in reducing pain and inflammation in RA, gout and psoriatic
arthritis.
pain relief in patients undergone lamectomy.
Topical –eye drops inflammation.
18
19. 5.PYRAZOLONEDERIVATIVES
PHENYLBUTAZONE has good anti-inflammatory activity, and more
potent but has poorer analgesic , antipyretic effects.
Adverse effects:
phenylbutazone is more toxic than aspirin and poorly tolerated; and
cause gastrointestinal side effects , salt and water retention
hypothyrodism.
Haematological toxicity including agranulocytosis.
AZAPRAZONE is structurally related to phenylbutazone but is less
likely to cause agranulocytosis.
other drugs ..
Metamizol and Propiphenazone.
NOVALGIN,ANALGIN 500mg tab.
300-600 mg 3-4 times a day SARIDON.
19
20. OXICAMS(ENOLOICACIDDERIVATIVES)
Piroxicam is an oxicam derivative ,has good anti-inflammatory
,analgesic and antipyretic activity.
Is used for rheumatoid arthritis ,osteoarthritis ,ankylosing spondylitis,
acute musculoskeletalpain and postoperative pain, painful dental
lesions.
Dose :UGESIC 20mg tab,DOLONEX 20mg cap,20mg/ml inj.
Tenoxicam is simliar to piroxicam.
Many other oxicam being developed with idea obtaining one which is
non –ulcerogenic.
20
21. PREFERENTIALCOX-2 INHIBITORS
DICLOFENAC is an analgesic, antipyretic and antiinflammatory agent .
It almost selectively inhibits COX-2 as result is more ‘gastric –friendly’
And also has poor antiplatelet activity.
Gel is avaliable for topical application. Is used for postoperative pain ,
Rectal suppository and mouthwashes are also avaliable.
DICLOFENAC AND ACECLOFENAC are the most commonly used
NSAIDs.
Treatment of chronic inflammatory condition like rheumatoid arthritis and
osteoarthritis.
Acute musculoskeletal pain, painful dental lesions.
Postoperatively for relief of pain and inflammation.
Eye : to reduce ocular inflammation.
21
22. NEBUMETONE
Is an antiihflammatory agent with significant efficacy in
rheumatoid arthritis and osteoarthritis. It shows low incidence of side
effects ,and comparatively less ulcerogenic.
Is an prodrug and also preferentially inhibit COX-2.
DOSE:NABUFLAM 500mg tab ,NILTIS 500,750 mg tab.
NIMESULIDE
A sulfonamide compound ,has higher affinity for COX-2 than
COX-1 and in addition has antihistaminic and antiallergic property.
has analgesic,antipyretic and anti-inflammatory action like other
NSAIDs.
ADR: Nausea, epigastric pain,rashes,drowsiness, dizziness and
nephrotoxicity.
22
23. SELECTIVECOX–2 INHIBITORS
COXibs
NSAIDs are extremely useful drugs ,are poorly tolerated particularly
they are used for long periods .gastric irritation is common side effect.
Gastric irritation is the common side effect .
Seleective inhibition of COX-2 was found to be advantageous
because cox2 involved inflammation and COX 1 which protect on
gastrodueodenal mucosa is spared.
such as,
celecoxib
parececoxib
etoricoxib
These drugs have analgesic, antiinflammatory and antipyretic effects
like nonselective NSAIDs but less gastric ulcerogenic effects.
Do not inhibit platelet aggregation because cox -1 involved platelet
function.
23
24. CHOICEOFNONSTEROIDALANTIINFLAMMATORYDRUG
Mild –to-moderate pain with little inflammation : paractamol or low dose
inflammation.
Postoperative or simliar acute but short lasting pain :inj ketoroloc,
diclofenac.
A parentral NSAID may be employed for renal colic, acute gout , dental
pain, fractures.
Exacerbation of rheumatoid arthritis ,ankylosing spondylitis,acute gout,
acute rheumatic fever: indomethacin, naproxen.
Gastric intierance to NSAIDs ; a selective COX-2 inhibitor and have
developed peptic ulcer must receive proton pump inhibitor.
Patient with hypertension or other risk factor for heartattack/stoke:avoid
COX-2 inhibitor.
In children risk of Reye’s syndrome ,aspirin should avoided.
Pregnancy : paracetamol is safest .
24